PRONUCLEON

Welcome to the Brand page for “PRONUCLEON”, which is offered here for Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging;biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;pharmaceutical research and development services, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “PRONUCLEON” is believed to be currently owned by “Adlyfe, Inc.”


Owner:
ADLYFE, INC.
Owner Details
Description:
Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging;Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;Pharmaceutical research and development services, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials;
Categories: BIOMEDICAL COMPOUNDS